| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |